111 related articles for article (PubMed ID: 5731727)
1. The chemotherapy of rodent malaria. VII. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, 2: schizontocidal action in the albino mouse.
Peters W
Annu Rev Pharmacol; 1968 Dec; 62(4):488-94. PubMed ID: 5731727
[No Abstract] [Full Text] [Related]
2. The chemotherapy of rodent malaria. XIV. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 4. The response of normal and drug-resistant strains of Plasmodium berghei.
Peters W
Ann Trop Med Parasitol; 1971 Jun; 65(2):123-9. PubMed ID: 5090256
[No Abstract] [Full Text] [Related]
3. The chemotherapy of rodent malaria. 18. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 5. The blood schizontocidal action of some newer sulphonamides.
Peters W
Ann Trop Med Parasitol; 1973 Jun; 67(2):155-67. PubMed ID: 4578936
[No Abstract] [Full Text] [Related]
4. The action of sulphonamide-folic reductase inhibitor combinations against normal and drug-resistant strains of rodent malaria.
Peters W
Trans R Soc Trop Med Hyg; 1971; 65(1):11-2. PubMed ID: 5559915
[No Abstract] [Full Text] [Related]
5. The chemotherapy of rodent malaria. VI. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. I. Introduction and anti-vector studies.
Beesley WN; Peters W
Ann Trop Med Parasitol; 1968 Sep; 62(3):288-94. PubMed ID: 5714956
[No Abstract] [Full Text] [Related]
6. Studies on the antimalarial property of 4-methoxy-6-sulfanilamido-pyrimidine monohydrate (sulfamonomethoxine: DJ-1550) and on its effect on the chloroquine-resistant malaria.
Yoshinaga T; Tsutsumi Y; Tsunoda K; Yamamura Y
Arzneimittelforschung; 1970 Sep; 20(9):1206-10. PubMed ID: 4922319
[No Abstract] [Full Text] [Related]
7. The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action.
Knight DJ; Peters W
Ann Trop Med Parasitol; 1980 Aug; 74(4):393-404. PubMed ID: 7006531
[No Abstract] [Full Text] [Related]
8. The chemotherapy of rodent malaria, 8. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, part 3: the action of sulphormethoxine and pyrimethamine on the sporogonic stages.
Ramkaran AE; Peters W
Ann Trop Med Parasitol; 1969 Dec; 63(4):449-54. PubMed ID: 5384694
[No Abstract] [Full Text] [Related]
9. The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening.
Peters W; Davies EE; Robinson BL
Ann Trop Med Parasitol; 1975 Sep; 69(3):311-28. PubMed ID: 1098590
[TBL] [Abstract][Full Text] [Related]
10. [Criteria for the selection of sulfonamides for the treatment of rodent malaria (Plasmodium vinckei)].
Heischkeil R
Z Tropenmed Parasitol; 1972 Jun; 23(2):128-43. PubMed ID: 5050535
[No Abstract] [Full Text] [Related]
11. Sulphonamides and folic acid antagonists in malaria and toxoplasmosis.
GOODWIN LG
Proc R Soc Med; 1956 Nov; 49(11):871-3. PubMed ID: 13379419
[No Abstract] [Full Text] [Related]
12. Studies on the chemotherapy of malaria. (III). Treatment of falciparum malaria in the Gambia, with BRL 50216 (4,6-diamino-(3, 4-dichlorobenzyloxy)-1,2-dihydro-2 2-dimethyl-1,3,5-triazine hydrochloride) alone and in combination with sulphonamides,
Laing AB
Trans R Soc Trop Med Hyg; 1974; 68(2):133-8. PubMed ID: 4617937
[No Abstract] [Full Text] [Related]
13. The chemotherapy of rodent malaria, XXXVII. The in vivo action of two Mannich bases, WR 194,965 and WR 228,258 and an 8-aminoquinoline WR 225,448.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):561-5. PubMed ID: 6532327
[TBL] [Abstract][Full Text] [Related]
14. The chemotherapy of rodent malaria. II. Host-parasite relationships. 2. The relationship between chloroquine sensitivity and the age of the host cell.
Peters W
Ann Trop Med Parasitol; 1968 Jun; 62(2):246-61. PubMed ID: 5751426
[No Abstract] [Full Text] [Related]
15. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
16. [New trends in malaria therapy with folic acid antagonists].
Donno L; Ricciardi ML; Soldati M
Riv Parassitol; 1968 Jun; 29(2):101-9. PubMed ID: 4885131
[No Abstract] [Full Text] [Related]
17. Plasmodium berghei: combining folic acid antagonists for potentiation against malaria infections in mice.
Kinnamon KE; Ager AL; Orchard RW
Exp Parasitol; 1976 Aug; 40(1):95-102. PubMed ID: 780121
[No Abstract] [Full Text] [Related]
18. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
Peters W; Irare SG; Ellis DS; Warhurst DC; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):567-79. PubMed ID: 6398032
[TBL] [Abstract][Full Text] [Related]
19. Studies on anti-folate antimalarials in east Africa.
Ortelli F; Maxwell CA; Curtis J; Watkins WM
Parassitologia; 1999 Sep; 41(1-3):313-4. PubMed ID: 10697874
[TBL] [Abstract][Full Text] [Related]
20. The chemotherapy of rodent malaria. I. Host-parasite relationships. I. The virulence of infection in relation to drug resistance and time elapsed since isolation of the 'wild' strain.
Peters W
Ann Trop Med Parasitol; 1968 Jun; 62(2):238-45. PubMed ID: 5709223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
